Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002323033 | SCV002609361 | uncertain significance | Cardiovascular phenotype | 2022-09-19 | criteria provided, single submitter | clinical testing | The p.V1070A variant (also known as c.3209T>C), located in coding exon 26 of the JAG1 gene, results from a T to C substitution at nucleotide position 3209. The valine at codon 1070 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV005058278 | SCV005699708 | benign | Alagille syndrome due to a JAG1 point mutation | 2024-07-31 | criteria provided, single submitter | clinical testing |